Kelly K. Hunt
凯利·亨特
MD
Chair and Regents' Professor, Department of Breast Surgical Oncology乳腺外科肿瘤学系主任；大学督导教授
👥Biography 个人简介
Kelly Hunt is Chair of Breast Surgical Oncology at MD Anderson and a world authority on axillary lymph node management after neoadjuvant chemotherapy. Her research on omission of axillary lymph node dissection and sentinel node biopsy following systemic therapy has reshaped surgical oncology standards globally.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Sentinel Lymph Node After Neoadjuvant Chemotherapy
Led landmark studies demonstrating the accuracy of sentinel lymph node biopsy after neoadjuvant chemotherapy, enabling axillary de-escalation in node-positive patients achieving pathologic response.
Omission of ALND
Co-authored pivotal trials supporting omission of axillary lymph node dissection in selected patients, substantially reducing surgical morbidity including lymphedema.
Neoadjuvant Trial Leadership
Designed and led multiple prospective trials at MD Anderson evaluating surgical endpoints after neoadjuvant systemic therapy, establishing institutional and national protocols.
Representative Works 代表性著作
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 trial
JAMA (2013)
Established SLN biopsy accuracy after neoadjuvant chemotherapy in node-positive patients, enabling axillary surgery de-escalation in responders.
Factors predictive of residual axillary nodal disease after sentinel lymph node biopsy following neoadjuvant chemotherapy
Annals of Surgery (2016)
Identified factors predicting residual nodal disease to guide patient selection for omission of ALND.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
关注 凯利·亨特 的研究动态
Follow Kelly K. Hunt's research updates
留下邮箱，当我们发布与 Kelly K. Hunt（The University of Texas MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment